logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
T

Therapeutic Advances in Endocrinology and Metabolism

IF4.6
Papers545
Citations1764
Journal Papers 544
Publication Date
delete
Cardiovascular promise requires endpoint discipline: interpreting tirzepatide after SURPASS-CVOT
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-10-07
delete0
PREAI
deleteMulavagili Vijayasimha; Taniya Wadhwa
deleteShare
deleteSave
Impact of training type (virtual vs in-person) on long-term glycemic control in people with type 1 diabetes using minimed 780: A non-inferiority longitudinal study
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-28
delete0
PREAI
deleteAna María Gómez Medina; Diana Cristina Henao-Carrillo; Oscar Muñoz; María Lorena Alfonso-Pisco; Felipe Cabezas
deleteShare
deleteSave
Author’s reply to the letter to the editor by Yongzhang Qin and Shihua Hong, “Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome”
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-28
delete0
PREAI
deleteWilfredo Antonio Rivera-Martínez; Johnayro Gutiérrez Restrepo; Alejandro Román-González; Carlos Esteban Builes-Montaño
deleteShare
deleteSave
Serum testosterone and uric acid: Key biomarkers for predicting response to drospirenone/ethinyl estradiol tablets (II) in adolescents polycystic ovary syndrome
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-28
delete0
PREAI
deleteXuyong Chen; Yuanyuan Teng; Yue He; Jiaqi Gao; Mingyang Zhao; Hao Yan; Mengyu Li; Min Wang
deleteShare
deleteSave
Metabolic effects of GLP-1 and GLP-2 across fed, fasting, and starvation states: A systematic review with structured narrative synthesis
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-24
delete0
PREAI
deleteAime Patrick Niyomugabo; Leopold Ntakirutimana; Pelagie Izabayo; Clenie Isingizwe; Olufunke Onaadepo; Abdullateef Isiaka Alagbonsi
deleteShare
deleteSave
The uric acid-to-homocysteine ratio as a prognostic marker for all-cause and cardiovascular mortality: A national population-based study
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-22
delete0
PREAI
deleteChao Xuan; Ting-Ting Zhou; Jun-Jie Guo; Cong Zhao; Deng Pan; Qing-Wu Tian
deleteShare
deleteSave
Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist, retatrutide compared to the dual incretin receptor agonist, tirzepatide, for treatment of type 2 diabetes mellitus
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-22
delete0
PREAI
deleteAnastasia Tereshchenko; Belén Garay Gálvez; Javier Ananda Tello
deleteShare
deleteSave
Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-21
delete0
PREAI
deleteYu-Nan Huang; Pei-Yun Li; Kai-Wen Liu; Pin-Hung Li; Shao-Chia Chen; Jo-Ching Chen; Gideon Meyerowitz-Katz; Jing-Yang Huang; Pen-Hua Su
deleteShare
deleteSave
Dietary protein content and its impact on amino acid profile and appetite in patients with methylmalonic acidemia
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-17
delete0
PREAI
deleteEngin Köse; Neslihan Doğulu; Furkan Yolcu; Naci Polat; Fatma Tuba Eminoğlu
deleteShare
deleteSave
Hashimoto’s thyroiditis and ablation-zone involution after microwave ablation for low-risk papillary thyroid carcinoma: An overlap-weighted cohort study
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-16
delete0
PREAI
deleteSong Li; Ying Wei; Zhen-long Zhao; Li-li Peng; Yan Li; Ming-an Yu
deleteShare
deleteSave
Association between the ratio of uric acid to high-density lipoprotein cholesterol (UHR) and the abnormal risk of sarcopenia: Evidence from two large population-based surveys and interpretable machine learning-driven sarcopenia screening
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-11
delete0
PREAI
deleteYunnong Luo; Aisheng Wang; Minfei Wu; Yang Wang
deleteShare
deleteSave
Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-08
delete0
PREAI
deleteXian-Pei Heng; Liu-Qing Yang; Qi-Wei Chen; Lin-Xi Jin; Yu-Wan Li; Yi Ruan; Zhuang Han; Shu-Hong Yao; Xin-Miao Hong; Zhi-Ta Wang; Liang Li; Wei-Dong He
deleteShare
deleteSave
Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999–2023
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-06
delete0
PREAI
deleteSongshan Li; Shuling Rong; Bin Yang; Huili Cao; Huwei Dai; Yajing Zhao; Bao Li
deleteShare
deleteSave
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-09-02
delete0
PREAI
deleteAndrew Dauber; Ravi Savarirayan; Ricki Carroll; Moira Cheung; Valérie Cormier-Daire; Mohamad Maghnie; Noriyuki Namba; Oliver Semler; Sajda Ghani; Ian Sabir; Roberto Bassi
deleteShare
deleteSave
GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-08-26
delete0
PREAI
deleteDured Dardari
deleteShare
deleteSave
Teplizumab in stage 2 type 1 diabetes- pediatric considerations, realistic expectations, and the evolving technological landscape
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-08-24
delete0
PREAI
deleteHussein Zaitoon
deleteShare
deleteSave
Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-08-21
delete0
PREAI
deleteYongzhang Qin; Shihua Hong
deleteShare
deleteSave
From traditional to novel: a national cohort study on the predictive value of C-reactive protein–triglyceride–glucose-obesity composite parameters for cardiovascular disease
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-08-11
delete0
PREAI
deleteMengjie Zhao; Xujie Wang; Xuexue Zhang; Yan Yan; Zirong Li; Fang Lu; Qiuyan Li
deleteShare
deleteSave
Facilitators, barriers, and interventions for exercise adherence in patients with prediabetes: a mixed-methods systematic review
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-07-31
delete0
PREAI
deleteYijia Yuan; Min Deng; Huan Chen; Xianying Lu; Xinyu Chen; Dingxi Bai; Huiting Gao; Chaoming Hou; Jing Gao
deleteShare
deleteSave
Beyond glycemic control: clinical cardiovascular effects of tirzepatide—a narrative review
deleteTherapeutic Advances in Endocrinology and Metabolism
IF4.6
delete2026-07-28
delete0
PREAI
deleteAzza O. Alawad; Tarig H. Merghani; Tarig E. Fadelelmoula; Nasir Abdelrafie Elamin; Shahenaz Satti; Alhiedi Ali Edris; Alwaleed Hakim; Rima Fathi El-Hindi; Ahmed Abdalla Alhaj-Ali; Wasil Elnour Ibrahim; Muhanad Ahmed Mustafa; Maymouna Mohieldin Sirelkhatim; Hany Hatim Ahmed; Nadia Osman Yousif
deleteShare
deleteSave